Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Adaptimmune Therapeutics

    NASDAQ: ADAP · Real-Time Price · USD
    0.28
    -0.00 (-1.06%)
    At close: Jun 09, 2025, 3:58 PM

    Adaptimmune Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -1.92 -1.4 -1.42 -3.7
    PEG Ratio
    		 0.04 0.03 n/a -0.28
    PS Ratio
    		 0.76 2.65 8.67 95.02
    PB Ratio
    		 11.47 4.04 2.87 2.84
    P/FCF Ratio
    		 -1.79 -1.09 -1.37 299.93
    P/OCF Ratio
    		 -1.86 -1.13 -1.66 54.46
    OCF/S Ratio
    		 -0.41 -2.34 -5.22 1.74
    Debt / Equity Ratio
    		 6.26 0.64 0.28 0.12
    Quick Ratio
    		 2.80 2.85 3.96 6.64
    Current Ratio
    		 2.92 2.85 3.96 6.64
    Asset Turnover
    		 0.72 0.21 0.08 0.01
    Interest Coverage
    		 -20.54 n/a n/a n/a
    Return on Equity
    		 -5.98 -2.88 -2.02 -0.77
    Return on Assets
    		 -0.29 -0.4 -0.5 -0.34
    Return on Invested Capital
    		 -0.39 -0.65 -0.62 -0.4
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 1.00 0.84 -3.7 -17.07
    Net Profit Margin
    		 -0.4 -1.89 -6.09 -25.71
    Pretax Profit Margin
    		 -0.38 -1.87 -6 -25.58
    Operating Profit Margin
    		 -0.39 -2.29 -6.04 -26.39
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 -0.3 -2.13 -5.73 -25.32

    Add to Watchlist